Better Understanding the Timing of Androgen Deprivation (TOAD) Trial Outcomes: Impacts of Prior ADT.
Read MoreWho is bothered most by ADT side effects and why?
Symptom burden profiles in men with advanced prostate cancer undergoing androgen deprivation therapy.
Read MoreA very readable and comprehensive review of ADT… with a comment on what ethnicities might benefit most from ADT
Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer.
Read MoreIs there a link between ADT and the risk of thyroid disease?
Androgen deprivation therapy for prostate cancer and the risk of thyroid diseases.
Read MoreHow important is bone mineral density testing for men on ADT?
Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer.
Read MoreADT can be psychologically distressing, but is that distress being treated correctly?
Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy.
Read MoreDoes a bit of add-back estradiol improve cognitive function for men on ADT?
Effect of estradiol on cognition in men undergoing androgen deprivation therapy: A randomized placebo-controlled trial.
Read MoreNo surprise – there’s a benefit to starting exercise before you start on ADT
A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND).
Read MoreWho in the real world goes on ADT along with radiotherapy to treat intermediate risk prostate cancer?
Trends in Androgen Deprivation Use in Men with Intermediate Risk Prostate Cancer Who Underwent Radiotherapy.
Read MoreOn metabolic syndrome, statin drugs, and prostate cancer progression
Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer.
Read More